J Korean Med Assoc.  2014 Dec;57(12):1034-1040. 10.5124/jkma.2014.57.12.1034.

Antihypertensive drug therapy: a review based on recent guidelines

Affiliations
  • 1Department of Medicine/Cardiology, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea. mdparkjb@gmail.com

Abstract

In 2013 and 2014, many guidelines regarding the management of hypertension were released from various worldwide professional bodies. These guidelines are similar in their recommendations, but some differences are evident due to different choices and interpretations of evidence from clinical trials used in setting the guidelines. A noticeable change that is common to all the guidelines is an increase in the target blood pressure for the treatment of hypertension to 140/90 mmHg. The guidelines also introduce invasive approaches, such as renal sympathetic denervation, as additional measures to better manage resistant hypertension. This review gives a summary of recent guidelines from North America, Europe, and Asia for the management of hypertension, with a focus on pharmacological treatment, and compares these guidelines with the Korean guidelines.

Keyword

Hypertension; Drug; Resistant hypertension

MeSH Terms

Asia
Blood Pressure
Drug Therapy*
Europe
Hypertension
North America
Sympathectomy
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr